Purpose New coronavirus disease 2019 (COVID-19) has a worse prognosis in patients with diabetes. However, there are insufficient data about the effect of hyperglycemia on COVID-19 prognosis in non-diabetic patients. This study aimed to investigate the relationship between random blood glucose levels measured at the time of diagnosis and prognosis of COVID-19 disease in non-diabetic patients. Methods A nationwide retrospective cohort of non-diabetic patients with confirmed COVID-19 infection from 11 March to 30 May 2020 in the Turkish Ministry of Health database was investigated. The patients were stratified into three groups according to blood glucose levels which were <100 mg/dL in group-1, in the range of 100-139 mg/dl in group-2, and the...
Background Coronavirus disease 2019 (COVID-19) has been reported to be associated with a more severe...
Background: Coronavirus disease 2019 (COVID-19) is an emerging infectious disease that first appeare...
Introduction To evaluate whether outpatient insulin treatment, hemoglobin A1c (HbA1c), glucose on ad...
Purpose New coronavirus disease 2019 (COVID-19) has a worse prognosis in patients with diabetes. How...
Introduction With intense deficiency of medical resources during COVID-19 pandemic, risk stratificat...
Background. Diabetes mellitus (DM) is one of the most common chronic diseases, the main manifestatio...
OBJECTIVE To explore whether at-admission hyperglycemia is associated with worse outcomes in patient...
Hyperglycaemia has emerged as an important risk factor for death in coronavirus disease 2019 (COVID-...
Background: Hyperglycaemia has emerged as an important risk factor for death in coronavirus disease ...
Abstract Aim Diabetes has been identified as a risk factor for poor outcomes in patients with COVID‐...
ImportancePatients with diabetes are known to be at increased risk for infections including severe c...
peer reviewedDiabetes mellitus is challenging in the context of the COVID-19 pandemic. The prevalenc...
Objective. Coronavirus disease 2019 (COVID-19) is a considerable global public health threat. This s...
Background: COVID-19 often causes severe complications in patients with metabolic disorders such as ...
A great global concern is currently focused on the coronavirus disease 2019 (COVID-19) pandemic and ...
Background Coronavirus disease 2019 (COVID-19) has been reported to be associated with a more severe...
Background: Coronavirus disease 2019 (COVID-19) is an emerging infectious disease that first appeare...
Introduction To evaluate whether outpatient insulin treatment, hemoglobin A1c (HbA1c), glucose on ad...
Purpose New coronavirus disease 2019 (COVID-19) has a worse prognosis in patients with diabetes. How...
Introduction With intense deficiency of medical resources during COVID-19 pandemic, risk stratificat...
Background. Diabetes mellitus (DM) is one of the most common chronic diseases, the main manifestatio...
OBJECTIVE To explore whether at-admission hyperglycemia is associated with worse outcomes in patient...
Hyperglycaemia has emerged as an important risk factor for death in coronavirus disease 2019 (COVID-...
Background: Hyperglycaemia has emerged as an important risk factor for death in coronavirus disease ...
Abstract Aim Diabetes has been identified as a risk factor for poor outcomes in patients with COVID‐...
ImportancePatients with diabetes are known to be at increased risk for infections including severe c...
peer reviewedDiabetes mellitus is challenging in the context of the COVID-19 pandemic. The prevalenc...
Objective. Coronavirus disease 2019 (COVID-19) is a considerable global public health threat. This s...
Background: COVID-19 often causes severe complications in patients with metabolic disorders such as ...
A great global concern is currently focused on the coronavirus disease 2019 (COVID-19) pandemic and ...
Background Coronavirus disease 2019 (COVID-19) has been reported to be associated with a more severe...
Background: Coronavirus disease 2019 (COVID-19) is an emerging infectious disease that first appeare...
Introduction To evaluate whether outpatient insulin treatment, hemoglobin A1c (HbA1c), glucose on ad...